Skip to content

Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch

Phase IV Study of the Choice of Optimal Strategy for Bifurcation Lesions With Normal Side Branch

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00694005
Acronym
CROSS
Enrollment
504
Registered
2008-06-09
Start date
2008-01-31
Completion date
2015-01-31
Last updated
2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

stent, bifurcation, balloon angioplasty

Brief summary

Few data are available about the late patency of side branches in association with the currently used stent types and implantation techniques.

Detailed description

Among the bifurcation type, bifurcation lesion without significant side branch stenosis (\<50%) usually did not require side branch stenting, but owing to several putative mechanism including dissection, thrombosis formation, embolization of plaque debris, ostial compromise by displaced stent strut, and snow plow effect, the side branch might be compromised. In this situation, the strategy to achieve optimal results has not been reported. Recently, FFR study showed that most jailed side branch (vessel size \>2.0 mm. DS\>50%) after main branch stenting did not have functional significance. We compared strategies with or without routine kissing balloon dilatation for less than 50% stenosis after simple DES crossing for bifurcation lesions (bifurcation type 1.1.0, 1.0.0, and 0.1.0 according to Medina classification) with serial change of FFR measurement.

Interventions

PROCEDUREkissing balloon

simultaneous kissing balloon angioplasty during drug-eluting stent implantation for bifurcation coronary lesions

PROCEDUREwithout kissing balloon angioplasty leave alone

simultaneous kissing balloon angioplasty during drug-eluting stent implantation for bifurcation coronary lesions

Sponsors

CardioVascular Research Foundation, Korea
CollaboratorOTHER
Seung-Jung Park
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Clinical * Patients with angina and documented ischemia or patients with documented silent ischemia * Patients who are eligible for intracoronary stenting * Age \>18 years, \<75 ages * Angiographic * De novo lesion located in a major bifurcation point with the MEDINA classification type 1.1.0, 1.0.0, or 0.1.0 * Main vessel : \>= 2.5 mm in vessel size, \>= 50% in diameter stenosis and =\< 50 mm in lesion length by visual estimation, in which the lesion is covered with =\< 2 stents * Side branch :\>= 2.0 mm in vessel size and \< 50% diameter stenosis by visual estimation

Exclusion criteria

* History of bleeding diathesis or coagulopathy * Pregnant * Known hypersensitivity or contra-indication to contrast agent, heparin, sirolimus, paclitaxel and zotarolimus * Limited life-expectancy (less than 1 year) due to combined serious disease * ST-elevation acute myocardial infarction =\< 2 weeks * Characteristics of lesion: * Left main disease * In-stent restenosis * Graft vessels * TIMI flow =\< grade 2 in the side branch * Chronic total occlusion * Renal dysfunction, creatinine \>= 2.0mg/dL * Contraindication to aspirin, clopidogrel or cilostazol

Design outcomes

Primary

MeasureTime frameDescription
Diameter stenosis at 8-month follow-up between the kissing balloon inflation and leave alone strategy8 months8 month after PCI

Secondary

MeasureTime frameDescription
Angiographic reocclusion rate of side branch8 months8month after PCI
Angiographic restenosis rate of side branch and the main vessel8 months8month after PCI
Late loss of side branch and the main vessel between angiography- and FFR-guided side branch procedure8 months8month after PCI
Angiographic reocclusion, restenosis rate and late loss of the side branch according to the DES type8 months8month after PCI
Angiographic reocclusion, restenosis rate and late loss of the side branch according to bifurcation angle and bifurcation type8 months8month after PCI
Composite of major cardiac adverse events (MACE) including death, MI, stent thrombosis and target vessel revascularization2 years
Incidence of side branch jail after main vessel stenting according to the stent type usedDay 1Day 1 (24 hours after the index procedure)
Incidence of peri-procedural cardiac enzyme elevationDay 1Day 1 (24 hours after the index procedure)
Fluoroscopic timeDay 1Day 1 (immediately after the index procedure)
Procedure timeDay 1Day 1 (immediately after the index procedure)
Amount of contrast agentDay 1Day 1 (immediately after the index procedure)
Number of used stentsDay 1Day 1 (immediately after the index procedure)
FFR of the side branch at post-procedure and at follow-upDay 1, 8 monthsDay 1 (immediately after the index procedure)and 8month after PCI

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026